A Randomized, Double-Blind, Placebo-Controlled, Titration-to-Effect Study of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Difelikefalin (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Cara Therapeutics
- 18 Jul 2017 Status changed from recruiting to completed.
- 29 Jun 2017 Top-line results (n = 476) published in a Cara Therapeutics media release.
- 09 Mar 2017 Top-line data from this trial is expected in the second quarter of 2017, according to a Cara Therapeutics media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History